ATE200912T1 - Pseudotypisierte retrovirale vektoren - Google Patents

Pseudotypisierte retrovirale vektoren

Info

Publication number
ATE200912T1
ATE200912T1 AT96909135T AT96909135T ATE200912T1 AT E200912 T1 ATE200912 T1 AT E200912T1 AT 96909135 T AT96909135 T AT 96909135T AT 96909135 T AT96909135 T AT 96909135T AT E200912 T1 ATE200912 T1 AT E200912T1
Authority
AT
Austria
Prior art keywords
pseudotyped retroviral
retroviral vector
retroviral vectors
pseudotyped
virus
Prior art date
Application number
AT96909135T
Other languages
English (en)
Inventor
Brian Salmons
Joerg Baumann
Original Assignee
Austrian Nordic Biotherapeutic
Gsf Forschungszentrum Umwelt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Austrian Nordic Biotherapeutic, Gsf Forschungszentrum Umwelt filed Critical Austrian Nordic Biotherapeutic
Application granted granted Critical
Publication of ATE200912T1 publication Critical patent/ATE200912T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051—Methods of production or purification of viral material
    • C12N2740/13052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Eye Examination Apparatus (AREA)
  • Optical Radar Systems And Details Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT96909135T 1995-03-29 1996-03-27 Pseudotypisierte retrovirale vektoren ATE200912T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK32795 1995-03-29
PCT/EP1996/001348 WO1996030533A1 (en) 1995-03-29 1996-03-27 Pseudotyped retroviral particles

Publications (1)

Publication Number Publication Date
ATE200912T1 true ATE200912T1 (de) 2001-05-15

Family

ID=8092296

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96909135T ATE200912T1 (de) 1995-03-29 1996-03-27 Pseudotypisierte retrovirale vektoren

Country Status (8)

Country Link
EP (1) EP0817860B1 (de)
JP (1) JPH11502706A (de)
AT (1) ATE200912T1 (de)
AU (1) AU5274696A (de)
DE (1) DE69612660T2 (de)
DK (1) DK0817860T3 (de)
ES (1) ES2157435T3 (de)
WO (1) WO1996030533A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11507244A (ja) * 1995-10-05 1999-06-29 カイロン コーポレイション Ｓｒｖ−３エンベロープ糖タンパク質配列で偽型化したレトロウイルスベクター
DK0975783T3 (da) * 1997-02-27 2002-01-28 Bundesrepublik Deutschland Let Retrovirusvektorer, fremgangsmåde til fremstilling heraf samt deres anvendelse til genoverføring til CD4-positive celler
WO1998053063A2 (en) * 1997-05-16 1998-11-26 Leuven Research & Development Vzw Mammalian cell transduction for use in gene therapy
EP0938904A1 (de) * 1998-02-09 1999-09-01 Leuven Research & Development vzw Säugetierzelltransduktion zur Verwendung in Gentherapie
FR2779445B1 (fr) * 1998-06-08 2000-08-11 Univ Nantes Kit d'encapsidation
GB0400443D0 (en) 2004-01-09 2004-02-11 Oxford Biomedica Ltd Cascade
WO2003025191A2 (en) * 2001-09-21 2003-03-27 Oxford Biomedica (Uk) Limited Pseudotyped retroviral vector system
CN121605184A (zh) * 2023-07-20 2026-03-03 香港北恒生物科技有限公司 逆转录病毒包装细胞及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU680508B2 (en) * 1993-04-06 1997-07-31 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Gibbon ape leukemia virus-based retroviral vectors

Also Published As

Publication number Publication date
WO1996030533A1 (en) 1996-10-03
EP0817860A1 (de) 1998-01-14
DE69612660T2 (de) 2002-04-18
ES2157435T3 (es) 2001-08-16
DE69612660D1 (de) 2001-06-07
JPH11502706A (ja) 1999-03-09
AU5274696A (en) 1996-10-16
EP0817860B1 (de) 2001-05-02
DK0817860T3 (da) 2001-10-01

Similar Documents

Publication Publication Date Title
GB2331522A (en) Lentiviral vectors
AU2998597A (en) Crossless retroviral vectors
GB2325003A (en) Rectroviral vectors
WO1995030763A3 (en) Retroviral vectors having a reduced recombination rate
WO1999004026A3 (en) Lentiviral vectors
DE69829471D1 (de) Auf lentivirus basierende gentransfer-vektoren
WO1992005266A3 (en) Packaging cells
WO2000000600A3 (en) Lentiviral vectors, comprising modified major donor splice sites and major packaging signals
WO1997007225A3 (en) High efficiency retroviral packaging system
ATE200912T1 (de) Pseudotypisierte retrovirale vektoren
DE3855134D1 (de) Monoklonale menschliche antikörper gegen hiv-i
NO975813D0 (no) Innkapslede celler som produserer virale partikler
DE3789400D1 (de) Für ein Glykoprotein des AIDS-Virus kodierende Virus-Vektoren, Vakzin und Antikörper.
DE69739251D1 (de) Nicht-m nicht-o hiv-1-stamm, fragmente und verwendungen
CA2464268A1 (en) Regulated nucleic acid expression system
WO2002042482A3 (en) Functional lentiviral vector from an mlv-based backbone
ES2184059T3 (es) Vector retrovirico y su utilizacion en terapia genica.
NO20002013D0 (no) Suspensjonsforpakningscellelinjer for retrovirusvektorer
WO1995025806A3 (en) Packaging-deficient lentiviruses
CA2331440A1 (en) Amphotropic retrovirus packaging cell line, process for its production and use thereof
AU1905300A (en) Selection system for generating efficient packaging cells for lentiviral vectors
WO1999025862A3 (en) Chimeric viral packaging signal without gag gene sequences

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner